Skip to main content

Alexander Hawkins, MD, MPH

  • Associate Professor of Surgery

Alexander Hawkins, MD, MPH

  • Associate Professor of Surgery

alex.hawkins@vumc.org

Research Program

Research Description

Have any questions? Contact Us 1-877-936-8422 for more information

Michael Hopkins, MD

  • Associate Professor of Surgery

Michael Hopkins, MD

  • Associate Professor of Surgery

ben.hopkins@vumc.org

Research Program

Research Description

Have any questions? Contact Us 1-877-936-8422 for more information

Sophoclis Alexopoulos, M.D.

  • Chief, Hepatobiliary Surgery and Liver Transplantation
  • Associate Professor of Surgery

Sophoclis Alexopoulos, M.D.

  • Chief, Hepatobiliary Surgery and Liver Transplantation
  • Associate Professor of Surgery

sopho.alexopoulos@vumc.org

Research Program

Research Description

Have any questions? Contact Us 1-877-936-8422 for more information

Theresa Sberna, M.P.H.

  • Chief Business Officer
  • Deputy Director for Strategy and Analytics

Phone

(615) 875-8720

Email

theresa.sberna@vumc.org
Vanderbilt-Ingram Cancer Center
691 Preston Research Building
2220 Pierce Ave
Nashville, TN 37232

Theresa Sberna, M.P.H.

  • Chief Business Officer
  • Deputy Director for Strategy and Analytics

(615) 875-8720

theresa.sberna@vumc.org

Vanderbilt-Ingram Cancer Center
691 Preston Research Building
2220 Pierce Ave
Nashville, TN 37232

Research Program

Have any questions? Contact Us 1-877-936-8422 for more information

Rebecca J. Selove, Ph.D., M.P.H.

  • Research Associate Professor (Tennessee State University)
  • Adjunct Associate Professor of Psychiatry and Behavioral Sciences (Vanderbilt University)

Phone

(615) 963-2558

Email

rebecca.selove@vanderbilt.edu
Tennessee State University
Center for Prevention Research
3500 John A. Merritt Blvd.
Nashville, TN 37209

Rebecca J. Selove, Ph.D., M.P.H.

  • Research Associate Professor (Tennessee State University)
  • Adjunct Associate Professor of Psychiatry and Behavioral Sciences (Vanderbilt University)

(615) 963-2558

rebecca.selove@vanderbilt.edu

Tennessee State University
Center for Prevention Research
3500 John A. Merritt Blvd.
Nashville, TN 37209

Research Program

Have any questions? Contact Us 1-877-936-8422 for more information

Claudia Barajas

  • Manager, Community Engagement

Phone

(615) 875-7560

Email

claudia.p.barajas@vumc.org
VICC Community Outreach and Engagement Office
691 Preston Research Building
2220 Pierce Ave
Nashville, TN 37232

Claudia Barajas

  • Manager, Community Engagement

(615) 875-7560

claudia.p.barajas@vumc.org

VICC Community Outreach and Engagement Office
691 Preston Research Building
2220 Pierce Ave
Nashville, TN 37232

Research Program

Have any questions? Contact Us 1-877-936-8422 for more information
Difluoromethylornithine (DFMO) will be used in an open label, single agent, multicenter, study for patients with neuroblastoma in remission. In this study subjects will receive 730 Days of oral difluoromethylornithine (DFMO) at a dose of 750 mg/m2 250 mg/m2 BID (strata 1, 2, 3, and 4) OR 2500 mg/m2 BID (stratum 1B) on each day of study. This study will focus on the use of DFMO in high risk neuroblastoma patients that are in remission as a strategy to prevent recurrence.

Why is research advocacy important?

Advocating for cancer research advancement is critical to finding new, and better treatments for cancer patients. In collaboration with bench, translational and clinical researchers, research advocates have the opportunity to:

Subscribe to